Literature DB >> 7426395

Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysis.

C W Norden, R L Myerowitz, E Keleti.   

Abstract

A previously-described experimental model of bacterial osteomyelitis was used to investigate systematically the sequential radiographic and histopathological changes in the tibias of rabbits infected with either Staphylococcus aureus or Pseudomonas aeruginosa. The radiographic changes induced by both organisms were progressive, increasing in severity from the first to the fourth week after infection. The severity and extent of radiographic changes, especially that of bond destruction, were significantly greater for tibias infected with S. aureus. Histopathologically, staphylococcal disease was a severe, rapidly progressive purulent infection which led to extensive destruction of marrow and cortical bone, formation of sequestra, and frequent extraosseous extension. Disease due to P. aeruginosa was more indolent and less destructive, leading to earlier healing and no extraosseous extension. The sequential radiographic and pathological changes observed with this experimental model closely resemble those described in man and suggest that this model may be useful for future investigations of pathogenesis and therapy.

Entities:  

Mesh:

Year:  1980        PMID: 7426395      PMCID: PMC2041602     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  9 in total

1.  Xeroradiographic, bacteriologic, and pathologic studies in experimental staphylococcus osteomyelitis.

Authors:  L R Crane; C C Kapdi; J N Wolfe; B K Silberberg; A M Lerner
Journal:  Proc Soc Exp Biol Med       Date:  1977-11

2.  Experimental osteomyelitis. II. Therapeutic trials and measurement of antibiotic levels in bone.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

3.  Experimental osteomyelitis. I. A description of the model.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

4.  Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin.

Authors:  G I Van Wingerden; V Lolans; G G Jackson
Journal:  J Bone Joint Surg Am       Date:  1974-10       Impact factor: 5.284

5.  The value of prophylactic penicillin in experimental osteomyelitis.

Authors:  D B Stevens
Journal:  J Surg Res       Date:  1966-10       Impact factor: 2.192

6.  Experimental osteomyelitis. V. Therapeutic trials with oxacillin and sisomicin alone and in combination.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

7.  Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

8.  Experimental osteomyelitis caused by Pseudomonas aeruginosa.

Authors:  C W Norden; E Keleti
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

9.  Therapy with hyperbaric oxygen for experimental osteomyelitis due to Staphylococcus aureus in rabbits.

Authors:  J T Mader; J C Guckian; D L Glass; J A Reinarz
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

  9 in total
  16 in total

1.  Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.

Authors:  Christopher Faber; Hein P Stallmann; D M Lyaruu; Uwe Joosten; Christof von Eiff; Arie van Nieuw Amerongen; Paul I J M Wuisman
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 2.  Biomaterials approaches to treating implant-associated osteomyelitis.

Authors:  Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

3.  Gentamicin-loaded borate bioactive glass eradicates osteomyelitis due to Escherichia coli in a rabbit model.

Authors:  Zongping Xie; Xu Cui; Cunju Zhao; Wenhai Huang; Jianqiang Wang; Changqing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

4.  Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a drug delivery system in the treatment of bone infection.

Authors:  Xin Liu; Zongping Xie; Changqing Zhang; Haobo Pan; Mohamed N Rahaman; Xin Zhang; Qiang Fu; Wenhai Huang
Journal:  J Mater Sci Mater Med       Date:  2009-10-15       Impact factor: 3.896

5.  Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.

Authors:  Wei-Tao Jia; Qiang Fu; Wen-Hai Huang; Chang-Qing Zhang; Mohamed N Rahaman
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

6.  A novel injectable borate bioactive glass cement for local delivery of vancomycin to cure osteomyelitis and regenerate bone.

Authors:  Xu Cui; Cunju Zhao; Yifei Gu; Le Li; Hui Wang; Wenhai Huang; Nai Zhou; Deping Wang; Yi Zhu; Jun Xu; Shihua Luo; Changqing Zhang; Mohamed N Rahaman
Journal:  J Mater Sci Mater Med       Date:  2014-01-30       Impact factor: 3.896

7.  In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis.

Authors:  Wei-Tao Jia; Shi-Hua Luo; Chang-Qing Zhang; Jian-Qiang Wang
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

8.  Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.

Authors:  C W Norden; M A Shaffer
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.

Authors:  Ling Yan; Dian-Ming Jiang; Zhi-Dong Cao; Jun Wu; Xin Wang; Zheng-Long Wang; Ya-Jun Li; Yong-Fen Yi
Journal:  Drug Des Devel Ther       Date:  2015-07-20       Impact factor: 4.162

10.  A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis.

Authors:  Hao Ding; Cun-Ju Zhao; Xu Cui; Yi-Fei Gu; Wei-Tao Jia; Mohamed N Rahaman; Yang Wang; Wen-Hai Huang; Chang-Qing Zhang
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.